Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Annals of the Rheumatic Diseases|July 18, 2025
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritisZiwei Hu, Shaozhe Cai, Yikai Yu, et al.Eclinicalmedicine|August 26, 2020
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort studyDan Liu, Pengfei Cui, Shaoqing Zeng, et al.Blood Advances|September 29, 2021
Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myelomaYing Wang, Chunrui Li, Jieyun Xia, et al.Blood|November 8, 2019
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignanciesNa Wang, Xuelian Hu, Wenyue Cao, et al.Clinical and Translational Medicine|March 30, 2021
A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemiaChunrui Li, Wenyue Cao, Yimei Que, et al.American Journal of Hematology|June 23, 2026
A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and PrognosisJing Li, Chenqi Yu, Jinghua Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2025
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA StudySikander Ailawadhi, Ivan Špička, Andrew Spencer, et al.Journal of Hematology & Oncology|July 14, 2025
Development and validation of a prognostic staging system for primary plasma cell leukemiaMengru Tian, Gang An, Weijun Fu, et al.Research Square|March 27, 2026
Dynamic Targetable Extracellular Vesicle Surface Proteins Monitor Depth of Response to CAR T-Cell TherapyYazhen Zhu, Chen Zhao, Lei Qiu, et al.Cancer Pathogenesis and Therapy|July 23, 2025
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone diseaseYutong Wang, Qiming Xu, Yuan Li, et al.Pageof 10